Your browser does not support JavaScript!
黃文鴻 教授

※黃文鴻 教授

個人網頁    English C.V












1968/10-1972/06 國立台灣大學藥學系

1975/06-1976/12 美國明尼蘇達大學藥事管理研究碩士

1976/12-1978/12 美國明尼蘇達大學社會與管理藥學博士


1981/07-1984/12 行政院衛生署藥政處副處長

1985/01-1988/12 行政院衛生署藥政處處長

1989/02-1994/01 行政院衛生署藥物食品檢驗局局長

1998/08-2001/07 國立陽明大學衛生福利研究所所長


1994/02-2006/07 國立陽明大學衛生福利研究所副教授

2006/08 迄今 國立陽明大學衛生福利研究所教授


        Tsai YW, Hsiao FY, Wen YW, Kao YH, Chang LC, Huang WF, Peng LN, Liu CL, Chen LK. Clinical Outcomes of Vertebroplasty or Kyphoplasty for Patients with Vertebral Compression Fractures: A Nationwide Cohort Study. Journal of the American Medical Directors Association 2013;14(1):41-47 (SCI).(Impact factor: 4.645;Rank: 8.89%)第四或以後作者

Kao YH, Chang LC, Huang WF, Tsai YW, Chen LK.. Health Characteristics of Older People Who Rotationally Live With Families: A Nationwide Survey. Journal of the American Medical Directors Association 2012;: (SCI).(Impact factor: 4.645;Rank: 8.89%)第三作者

Yeh HT, Hsieh CF, Tsai YW, Huang WF. Effects of thiazolidinediones on cardiovascular events in patients with type 2 diabetes mellitus after drug-eluting stent implantation: A retrospective cohort study using the National Health Insurance Database in Taiwan. CLINICAL THERAPEUTICS 2012;33(4):885-93 (SCI).(Impact factor: 2.321;Rank: 46.36%)第一或通訊作者

        Hsiao FY, Mullins CD, Wen YW, Huang WF, Chen PF and Tsai YW. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 2011;20(10):1043-9 (SCI).(Impact factor: 2.528;Rank: 40.61%)第四或以後作者

Wen YW, Tsai YW, Huang WF, Hsaio FY, Chen PF. The Potentially Inappropriate Prescription of New Drug: Thiazolidinediones for Patients with Type II Diabetes in Taiwan. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 2011;20:20-29 (SCI).(Impact factor: 2.528;Rank: 40.61%)第三作者

Tsai TW, Wen YW, Huang WF, Kuo KN, Chen PF, Shih HW, Lee YC. Cardiovascular and Gastrointestinal Events of Three Antiplatelet Therapies—Clopidogrel, Clopidogrel plus Proton-Pump Inhibitors, and Aspirin plus Proton-Pump Inhibitors in Patients with Previous Gastrointestinal Bleeding. Journal of GASTROENTEROLOGY 2011;46:39-45 (SCI).(Impact factor: 4.16;Rank: 18.92%)第三作者

Fei-Yuan Hsiao, Yi-Wen Tsai, Yu-Wen Wen, Ken N. Kuo,Chia-Rung Tsai, and Weng-Foung Huang. Effect of Helicobacter pylori Eradication Therapy on Risk of Hospitalization for a Major Ulcer Event. Pharmacotherapy 2011;31(3):239-247 (SCI).(Impact factor: 2.9;Rank: 32.57%)第一或通訊作者

Yu-Wen Wen, Weng-Foung Huang, Yue-Chune Lee, Ken N. Kuo, Chi-Rung Tsai and Yi-WenTsai. Diffusion Patterns of New Anti-diabetic Drugs into Hospitals in Taiwan: The Case of Thiazolidinediones for Diabetes. BMC Health Services Research 2011;11(1):21 (SCI).(Impact factor: 1.66;Rank: 48.68%)第二作者

Chi-Feng Hsieh, Po-Ying Chang, Pei-Yu Lu, Weng-Foung Huang. The patterns of outpatient off-label carbamazepine use and the potential impact of regulatory labeling process in Taiwan. Journal of Pharmaceutical Health Services Research 2011;2:165-173 (OI).第一或通訊作者

Pei-Yu Lu,Chi-Feng Hsieh,Weng-Foung Huang,Yi-Wen Tsai. Alendronate and Raloxifene Use Related to Cardiovascular Diseases: Differentiation by Different Dosing Regimens of Alendronate. CLINICAL THERAPEUTICS 2011;33(9):1173-9 (SCI).(Impact factor: 2.321;Rank: 46.36%)第一或通訊作者


1985 國立台灣大學校友總會 台灣大學傑出年輕校友獎

1988 行政院 公務人員保舉特優人員

1989 行政院 研究獎勵甲等獎

1992 亞洲藥事學會公共服務獎

1994 行政院衛生署乙等衛生獎章



Voice Play
Welcome to

Institute of Health  
and Welfare Policy